Recent Quotes
My Watchlist
Indicators
Local Stocks
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Heartbeam, Inc. - Common Stock (NQ:BEAT)

0.4022 -0.0036 (-0.89%)
Streaming Delayed Price Updated: 11:08 AM EDT, Sep 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Heartbeam, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
HeartBeam Announces Exercise and Closing of Underwriter’s Over-Allotment Option for Public Offering of Common Stock
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Prices $10 Million Public Offering at $1.70 Per Share
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Submits FDA Application for 12-Lead ECG Synthesis Software
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) to Present at JP Morgan 2025 Annual Healthcare Conference
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference
From HeartBeam, Inc.
Via Business Wire
News headline image
HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Secures FDA Clearance for Innovative Arrhythmia Assessment Device
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Presents Positive Data for Groundbreaking Technology at AHA Conference
Via Investor Brand Network
News headline image
HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Advances Toward Commercialization of Cardiac Care Technology with FDA Submissions and Key Leadership Appointments
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Reports Third Quarter 2024 Results
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q3 Earnings Call with Key Regulatory and Initiative Updates
Via Investor Brand Network
Topics Earnings Intellectual Property
News headline image
HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Wins 2024 Digital Health Hub Award for Innovation in Cardiac Care
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards
From HeartBeam, Inc.
Via Business Wire
Lifesaving Portable, AI Augmented Cardiac Monitoring Technology Poised for Commercial Launch Under New Industry Leader CEO: Heartbeam, Inc. (NASDAQ: BEAT)
Via Get News
Topics Artificial Intelligence
TechMediaBreaks – HeartBeam Inc. (NASDAQ: BEAT) Appoints Robert Eno as New CEO to Lead Next Phase of Growth and Innovation
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Industry Expert, Pioneer as New Chief AI Scientist
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Appoints Industry Expert as New CFO
Via Investor Brand Network
Topics Intellectual Property Retirement
News headline image
HeartBeam Names Timothy Cruickshank as Chief Financial Officer
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q2 2024 Financial Report, Operational Update
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
BEAT Stock Earnings: HeartBeam Misses EPS for Q2 2024 ↗
BEAT stock results show that HeartBeam missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
HeartBeam Reports Second Quarter 2024 Results
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces Conference Call, Webcast to Discuss Q2 Results
Via Investor Brand Network
News headline image
HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Now Listed on Russell Microcap Index
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.